Philip Gentlesk, M.D.
NPI 1528059862 · Clinical Cardiac Electrophysiology Physician · Norfolk, VA
Enrolled with Medicare as Practitioner - Cardiac Electrophysiology · source: CMS PECOS Public Provider Enrollment (2026.04.01)
Provider details
- NPI number
- 1528059862
- Entity type
- Individual
- Primary specialty
- Clinical Cardiac Electrophysiology PhysicianAllopathic & Osteopathic Physicians
- Credential
- M.D.
- Sex
- Male
- Sole proprietor
- No
- License
- M2328 (TX)
Specialties & taxonomies
Allopathic & Osteopathic Physicians
Allopathic & Osteopathic Physicians
Allopathic & Osteopathic Physicians
Allopathic & Osteopathic Physicians
Allopathic & Osteopathic Physicians
Profile Score
A profile completeness & documented-activity index — NOT a quality, outcomes, or patient-satisfaction rating.
- Registry tenure25% of score
20 yrs in NPPES registry
- Profile completeness25% of score
100% of core fields populated
- Practice footprint15% of score
1 documented practice location
- Medicare service volume (vs. specialty peers)25% of score
5,552 Medicare services, 2024 (ranked within specialty)
- Open Payments transparency10% of score
Has Open Payments disclosures (2024)
Medicare volume is ranked against active providers in the same specialty. Signals a provider has no public data for (e.g. Medicare claims) are left out of the score entirely — never counted as zero — so providers without that data are not penalized. See the full formula and weights in our .
What this provider does (Medicare)
Based on Medicare fee-for-service claims, 2024; not all care is captured.
| Service (HCPCS) | Medicare services | Typical Medicare-allowed (2024) |
|---|---|---|
| Routine Electrocardiogram (ecg) Using at Least 12 Leads With Interpretation and Report Only93010 | 1,339 | $8 |
| Evaluation of Single, Dual, Multiple Lead Or Leadless Pacemaker System, Remote Up to 90 Days93294 | 733 | $29 |
| Established Patient Office Or Other Outpatient Visit With Moderate Level of Decision Making, If Using Time, 30 Minutes Or More99214 | 306 | $97 |
| Evaluation of Single, Dual, Or Multiple Lead Implantable Defibrillator System, Remote Up to 90 Days93295 | 296 | $36 |
| Evaluation of Implantable Heart and Blood Vessel Monitoring System, Remote Up to 30 Days93297 | 250 | $25 |
| Subsequent Hospital Care With Moderate Levelof Medical Decision Making, If Using Time, at Least 50 Minutes |
What this provider prescribes (Medicare Part D)
Top drugs by Medicare Part D claim volume, 2024 · 14 distinct drugs on file.
| Drug | Part D claims (2024) | Beneficiaries |
|---|---|---|
| Apixabanbrand: Eliquis | 367 | 143 |
| Metoprolol Succinate | 188 | 78 |
| Flecainide Acetate | 149 | 62 |
| Carvedilol | 99 | 46 |
| Metoprolol Tartrate | 78 | 33 |
| Amiodarone Hcl | 58 | 28 |
| Rivaroxabanbrand: Xarelto | 57 |
Transparency — industry payments
Based on CMS Open Payments, 2024; not all care is captured.
$692 across 13 records (Open Payments 2024)
Open Payments discloses payments and transfers of value (meals, travel, consulting, research, royalties) from drug and device makers to providers. This is a transparency signal, not a verdict — such payments are legal and common, and their presence is neither an endorsement nor a criticism. Source: CMS Open Payments, program year 2024.
Practice location
Mailing address
Registry dates
- Enumerated
- 2005-11-04
- Last updated
- 2022-07-15
- Certified
- 2022-07-15
Source: CMS NPPES Data Dissemination (June 2026). NPI Central is not affiliated with CMS. Data is provided as-is from the public registry.